#BEGIN_DRUGCARD DB01827

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C8H5F4NO2

# Chemical_IUPAC_Name:
2,3,5,6-tetrafluoro-4-methoxybenzamide

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide

# HET_ID:
BEK

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C8H5F4NO2/c1-15-7-5(11)3(9)2(8(13)14)4(10)6(7)12/h1H3,(H2,13,14)

# InChI_Key:
InChIKey=JTXPTSGPUNTKSM-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1827

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
223.1244

# Molecular_Weight_Mono:
223.025641229

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1KJR

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
1.31

# Predicted_LogS:
-2.9

# Predicted_Water_Solubility:
3.09e-01 g/l

# Primary_Accession_No:
DB01827

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
657081

# PubChem_Substance_ID:
46504979

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00667

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
COC1=C(F)C(F)=C(C(N)=O)C(F)=C1F

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:31 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Nucleus. Note=Cytoplasmic in adenomas and carcinomas. May be secreted by a non-classical secretory p

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
LGALS3

# Drug_Target_1_GenBank_ID_Gene:
M57710

# Drug_Target_1_GenBank_ID_Protein:
179531

# Drug_Target_1_GeneCard_ID:
LGALS3

# Drug_Target_1_Gene_Name:
LGALS3

# Drug_Target_1_Gene_Sequence:
>753 bp
ATGGCAGACAATTTTTCGCTCCATGATGCGTTATCTGGGTCTGGAAACCCAAACCCTCAA
GGATGGCCTGGCGCATGGGGGAACCAGCCTGCTGGGGCAGGGGGCTACCCAGGGGCTTCC
TATCCTGGGGCCTACCCCGGGCAGGCACCCCCAGGGGCTTATCCTGGACAGGCACCTCCA
GGCGCCTACCATGGAGCACCTGGAGCTTATCCCGGAGCACCTGCACCTGGAGTCTACCCA
GGGCCACCCAGCGGCCCTGGGGCCTACCCATCTTCTGGACAGCCAAGTGCCCCCGGAGCC
TACCCTGCCACTGGCCCCTATGGCGCCCCTGCTGGGCCACTGATTGTGCCTTATAACCTG
CCTTTGCCTGGGGGAGTGGTGCCTCGCATGCTGATAACAATTCTGGGCACGGTGAAGCCC
AATGCAAACAGAATTGCTTTAGATTTCCAAAGAGGGAATGATGTTGCCTTCCACTTTAAC
CCACGCTTCAATGAGAACAACAGGAGAGTCATTGTTTGCAATACAAAGCTGGATAATAAC
TGGGGAAGGGAAGAAAGACAGTCGGTTTTCCCATTTGAAAGTGGGAAACCATTCAAAATA
CAAGTACTGGTTGAACCTGACCACTTCAAGGTTGCAGTGAATGATGCTCACTTGTTGCAG
TACAATCATCGGGTTAAAAAACTCAATGAAATCAGCAAACTGGGAATTTCTGGTGACATA
GACCTCACCAGTGCTTCATATACCATGATATAA

# Drug_Target_1_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_1_General_References:
2009535	Raz A, Carmi P, Raz T, Hogan V, Mohamed A, Wolman SR: Molecular cloning and chromosomal mapping of a human galactoside-binding protein. Cancer Res. 1991 Apr 15;51(8):2173-8.
2022338	Oda Y, Leffler H, Sakakura Y, Kasai K, Barondes SH: Human breast carcinoma cDNA encoding a galactoside-binding lectin homologous to mouse Mac-2 antigen. Gene. 1991 Mar 15;99(2):279-83.
2261464	Robertson MW, Albrandt K, Keller D, Liu FT: Human IgE-binding protein: a soluble lectin exhibiting a highly conserved interspecies sequence and differential recognition of IgE glycoforms. Biochemistry. 1990 Sep 4;29(35):8093-100.
2402511	Cherayil BJ, Chaitovitz S, Wong C, Pillai S: Molecular cloning of a human macrophage lectin specific for galactose. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7324-8.
7682704	Lotz MM, Andrews CW Jr, Korzelius CA, Lee EC, Steele GD Jr, Clarke A, Mercurio AM: Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3466-70.
8253806	Huflejt ME, Turck CW, Lindstedt R, Barondes SH, Leffler H: L-29, a soluble lactose-binding lectin, is phosphorylated on serine 6 and serine 12 in vivo and by casein kinase I. J Biol Chem. 1993 Dec 15;268(35):26712-8.
9501082	Sasaki T, Brakebusch C, Engel J, Timpl R: Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin. EMBO J. 1998 Mar 16;17(6):1606-13.
9582341	Seetharaman J, Kanigsberg A, Slaaby R, Leffler H, Barondes SH, Rini JM: X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution. J Biol Chem. 1998 May 22;273(21):13047-52.

# Drug_Target_1_HGNC_ID:
HGNC:6563

# Drug_Target_1_HPRD_ID:
17026

# Drug_Target_1_ID:
2467

# Drug_Target_1_Locus:
14q21-q22

# Drug_Target_1_Molecular_Weight:
26189

# Drug_Target_1_Name:
Galectin-3

# Drug_Target_1_Number_of_Residues:
250

# Drug_Target_1_PDB_ID:
1KJR

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00337	Gal-bind_lectin

# Drug_Target_1_Protein_Sequence:
>Galectin-3
MADNFSLHDALSGSGNPNPQGWPGAWGNQPAGAGGYPGASYPGAYPGQAPPGAYPGQAPP
GAYHGAPGAYPGAPAPGVYPGPPSGPGAYPSSGQPSAPGAYPATGPYGAPAGPLIVPYNL
PLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNN
WGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDI
DLTSASYTMI

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Galactose-specific lectin which binds IgE. May mediate with the alpha-3, beta-1 integrin the stimulation by CSPG4 of endothelial cells migration

# Drug_Target_1_SwissProt_ID:
P17931

# Drug_Target_1_SwissProt_Name:
LEG3_HUMAN

# Drug_Target_1_Synonyms:
35 kDa lectin
CBP 35
Carbohydrate-binding protein 35
GALBP
Galactose-specific lectin 3
Galactoside-binding protein
IgE-binding protein
L-31
Laminin-binding protein
Lectin L-29
Mac-2 antigen

# Drug_Target_1_Theoretical_pI:
8.82

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB01827
